Abstract |
Killer cell Ig-like receptors (KIRs) interact with HLA class I ligands to regulate NK cell development and function. These interactions affect the outcome of unrelated donor hematopoietic cell transplantation (HCT). We have shown previously that donors with KIR B versus KIR A haplotypes improve the clinical outcome for patients with acute myelogenous leukemia by reducing the incidence of leukemic relapse and improving leukemia-free survival (LFS). Both centromeric and telomeric KIR B genes contribute to the effect, but the centromeric genes are dominant. They include the genes encoding inhibitory KIRs that are specific for the C1 and C2 epitopes of HLA-C. We used an expanded cohort of 1532 T cell-replete transplants to examine the interaction between donor KIR B genes and recipient class I HLA KIR ligands. The relapse protection associated with donor KIR B is enhanced in recipients who have one or two C1-bearing HLA-C allotypes, compared with C2 homozygous recipients, with no effect due to donor HLA. The protective interaction between donors with two or more, versus none or one, KIR B motifs and recipient C1 was specific to transplants with class I mismatch at HLA-C (RR of leukemia-free survival, 0.57 [0.40-0.79]; p = 0.001) irrespective of the KIR ligand mismatch status of the transplant. The survival advantage and relapse protection in C1/x recipients compared with C2/C2 recipients was similar irrespective of the particular donor KIR B genes. Understanding the interactions between donor KIR and recipient HLA class I can be used to inform donor selection to improve outcome of unrelated donor hematopoietic cell transplantation for acute myelogenous leukemia.
|
Authors | Sarah Cooley, Daniel J Weisdorf, Lisbeth A Guethlein, John P Klein, Tao Wang, Steven G E Marsh, Stephen Spellman, Michael D Haagenson, Koy Saeturn, Martha Ladner, Elizabeth Trachtenberg, Peter Parham, Jeffrey S Miller |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 192
Issue 10
Pg. 4592-600
(May 15 2014)
ISSN: 1550-6606 [Electronic] United States |
PMID | 24748496
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- HLA-C Antigens
- Receptors, KIR
|
Topics |
- Allografts
- Disease-Free Survival
- Female
- HLA-C Antigens
(genetics, immunology)
- Haplotypes
(immunology)
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute
(genetics, immunology, mortality, therapy)
- Male
- Receptors, KIR
(genetics, immunology)
- Retrospective Studies
- Survival Rate
- Unrelated Donors
|